A Comprehensive Quality Evaluation System for Medicinal Leeches by Integrating Macromolecular Protein Analysis and Small-Molecule Marker Detection as Well as Quantitative Bioassays

<b>Background/Objectives:</b> Medical leech (<i>Hirudo</i> in the Chinese Pharmacopoeia) is renowned in traditional medicine for its significant antithrombin activity. As an animal-derived medicine with complex and incompletely understood composition, its insufficient quality control measures are met with widespread counterfeiting caused by limited animal resources and rising demand. <b>Methods:</b> In this study, an integrated quality evaluation strategy guided by "Totality of the Evidence" (TOE) method is proposed. This strategy combines chemical characterization of small and macromolecular components with bioassays relevant to its clinical functions. A total of 28 batches of samples were analyzed, comprising 23 genuine and 5 counterfeit batches. Species origins were identified by morphology and DNA barcoding. Chemical characterization included TLC, HPLC and UPLC-QTOF-MS/MS for small molecules, and SDS-PAGE with HPLC-Orbitrap Fusion Lumos Tribrid-MS for macromolecules. Antithrombotic activity was assessed by thrombin titration and platelet aggregation assays. <b>Results:</b> Several characteristic components were discovered and identified as key quality control markers, including eight small molecules such as an unreported compound SZ-1, plus seven major differential proteins across species. Based on these markers, accurate and rapid authentication methods were established using SDS-PAGE for macromolecules, and both HPLC and TLC for small molecules. Furthermore, using bioassay methods we established for quality evaluation, <i>Hirudo nipponica</i> exhibits potent anti-thrombin activity and inhibits platelet aggregation, while <i>Whitmania pigra</i> shows weak anti-thrombin activity and promotes platelet aggregation. <b>Conclusions:</b> This quality evaluation strategy is not only applicable for the quality assessment of genuine <i>Hirudo</i> products of different origins, but also for distinguishing medical leeches from their counterfeits.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2025-06-13
DOI
https://doi.org/10.3390/ph18060887
Primary Topic
Leech Biology and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Comprehensive Quality Evaluation System for Medicinal Leeches by Integrating Macromolecular Protein Analysis and Small-Molecule Marker Detection as Well as Quantitative Bioassays

Wei Lou, Hui‐Min Gao, Yufei Liu, Liang‐Mian Chen et al.
Pharmaceuticals
Leech Biology and Applications
article

A Comprehensive Quality Evaluation System for Medicinal Leeches by Integrating Macromolecular Protein Analysis and Small-Molecule Marker Detection as Well as Quantitative Bioassays

Wei Lou, Hui‐Min Gao, Yufei Liu, Liang‐Mian Chen, W Q Wang, Tianze Xie, Zhimin Wang, Yue Ma
article en

Abstract

<b>Background/Objectives:</b> Medical leech (<i>Hirudo</i> in the Chinese Pharmacopoeia) is renowned in traditional medicine for its significant antithrombin activity. As an animal-derived medicine with complex and incompletely understood composition, its insufficient quality control measures are met with widespread counterfeiting caused by limited animal resources and rising demand. <b>Methods:</b> In this study, an integrated quality evaluation strategy guided by "Totality of the Evidence" (TOE) method is proposed. This strategy combines chemical characterization of small and macromolecular components with bioassays relevant to its clinical functions. A total of 28 batches of samples were analyzed, comprising 23 genuine and 5 counterfeit batches. Species origins were identified by morphology and DNA barcoding. Chemical characterization included TLC, HPLC and UPLC-QTOF-MS/MS for small molecules, and SDS-PAGE with HPLC-Orbitrap Fusion Lumos Tribrid-MS for macromolecules. Antithrombotic activity was assessed by thrombin titration and platelet aggregation assays. <b>Results:</b> Several characteristic components were discovered and identified as key quality control markers, including eight small molecules such as an unreported compound SZ-1, plus seven major differential proteins across species. Based on these markers, accurate and rapid authentication methods were established using SDS-PAGE for macromolecules, and both HPLC and TLC for small molecules. Furthermore, using bioassay methods we established for quality evaluation, <i>Hirudo nipponica</i> exhibits potent anti-thrombin activity and inhibits platelet aggregation, while <i>Whitmania pigra</i> shows weak anti-thrombin activity and promotes platelet aggregation. <b>Conclusions:</b> This quality evaluation strategy is not only applicable for the quality assessment of genuine <i>Hirudo</i> products of different origins, but also for distinguishing medical leeches from their counterfeits.

PharmaceuticalsVol. 18(6)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
China Academy of Chinese Medical Sciences, National Key Research and Development Program of China
Openalex Percentile: Top 85%
Leech Biology and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.